Cryptococcal meningitis in the immunocompromised host: intracranial hypertension and other complications
- 94 Downloads
Cryptococcosis as a complication of the immunocompromised host has dramatically increased in frequency since the start of the AIDS epidemic. This trend has heightened awareness of the complications of cryptococcal meningitis; of these, intracranial hypertension is common, severe, and life-threatening, as exemplified by three cases in our institutions presented here in detail. An aggressive approach to management of this complication has not been the standard of care, but neurosurgical interventional studies combined with physiologic observations suggest early intervention may reduce the devastating morbidity and mortality.
Unable to display preview. Download preview PDF.
- 1.Kwon-Chung KJ, Bennett JE, eds. Cryptococcosis. In: Medical Mycology. Philadelphia: Lea and Febiger, 1992: 397–446.Google Scholar
- 4.Diamond RD. Cryptococcus neoformans. In: Mandell GL, Bennett JE, Dolin R, eds. Principles and Practice of Infectious Diseases, 4th ed. New York: Churchill Livingstone, 2331–2340.Google Scholar
- 9.Saag MS, Powderly WG, Cloud GA, Robinson P, Grieco MH, Sharkey PK, Thompson SE, Sugar AM, Tuazon CU, Fisher JF, Hyslop N, Jacobson JM, Hather R, Dismukes WE, and the NIAID Mycoses Study Group and the AIDS Clinical Trials Group. Comparison of amphotericin B with fluconazole in the treatment of acute AIDS-associated cryptococcal meningitis. N Engl J Med 1992; 326: 83–89.PubMedCrossRefGoogle Scholar
- 11.Van der Horst CM, Saag MS, Cloud GA, Hamill RJ, Graybill JR, Sobel JD, Johnson PC, Tuazon CU, Kerkering T, Moskovitz BL, Powderly WG, Dismukes WE, and the NIAID Mycoses Study Group and AIDS Clinical Trials Group. Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome. N Engl JMed 1997; 337: 15–21.CrossRefGoogle Scholar
- 12.Sharkey PK, Graybill JR, Johnson ES, Hausrath SG, Pollard RB, Kolokathis A, Mildvan D, Fan-Havard P, Eng RHK, Patterson TF, Pottage JC, Simberkoff MS, Wolf J, Meyer RD, Gupta R, Lee LW, Gordon DS. Amphotericin B lipid complex compared with amphotericin B in the treatment of cryptococcal meningitis in patients with AIDS. Clin Infect Dis 1996; 22: 315–321.PubMedGoogle Scholar
- 13.Clemons KV, Stevens DA. Comparison of Fungizone, Amphotec, AmBisome, and Abelcet for treatment of systemic murine cryptococcosis. Antimicrob Agents Chemother 1998; 42: 899–902.Google Scholar
- 14.Graybill JR, Sobel J, Saag M, van der Horst C, Powderly W, Cloud G and the NIAID Mycoses Study Group and the AIDS Clinical Trials Group. Cerebrospinal fluid (CSF) hypertension in patients with AIDS and cryptococcal meningitis (CM) (abstract). Interscience Conference on Antimicrobial Agents and Chemotherapy 1997: 271.Google Scholar
- 22.Bingaman WE, Frank JI Malignant cerebral edema and intracranial hypertension. Neurol Clinics 1995;13:479–509.Google Scholar
- 25.Park MK, Hospenthal DR, Bennett JE. Treatment of hydrocephalus secondary to cryptococcal meningitis by use of shunting. Clin Infect Dis 1999; 8: 629–633.Google Scholar
- 27.Fessler RD Sobel J, Guyot, L, Crane L, Vazquez J, Szuba MJ, Diaz FG. Management of elevated intracranial pressure in patients with cryptococcal meningitis. J Acquired Immunodeficiency Syndromes Human Retrovirol. 1998; 17: 137–142.Google Scholar
- 29.Mylonakis E, Merriman NA, Rich JD, Flanigan TP, Walters BC, Tashima KT, Mileno MD, Van der Horst CM. Use of cerebrospinal fluid shunt for the management of elevated intracranial pressure in patient with active AIDS-related cryptococcal meningitis. Diag Microbiol Infect Dis 1999; 34: 111–114.CrossRefGoogle Scholar